Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Longo

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Recenti Progressi in Medicina|January 29, 2021
[Efficacy of pralsetinib in a patient with advanced lung adenocarcinoma positive for RET rearrangement: the importance of Comprehensive Genomic Profiling.]Michele Montrone, Vito Longo, Annamaria Catino, et al.
Recenti Progressi in Medicina|November 2, 2012
[Bone health in the oncologic patient]Stella D'Oronzo, Antonella Tamma, Valeria Simone, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinibMichele Montrone, Annamaria Catino, Vincenzo O Palmieri, et al.
Recenti Progressi in Medicina|February 24, 2021
[RET rearrangements in advanced lung cancer: a target to always look for.]Annamaria Catino, Pia Perrotti, Sandro Cassiano, et al.
Cancer Metastasis Reviews|December 21, 2013
Bone metastases in hepatocellular carcinoma: an emerging issueVito Longo, Oronzo Brunetti, Stella D'Oronzo, et al.
Clinical and Experimental Medicine|March 2, 2018
Mast cells and angiogenesis in pancreatic ductal adenocarcinomaVito Longo, Roberto Tamma, Oronzo Brunetti, et al.
Thoracic Cancer|November 5, 2022
Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decadeVito Longo, Pamela Pizzutilo, Annamaria Catino, et al.
Cancers|April 18, 2019
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic ReviewVito Longo, Oronzo Brunetti, Amalia Azzariti, et al.
Cancers|May 14, 2025
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-AnalysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Biomolecules|April 27, 2024
Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?Rossella Fasano, Simona Serratì, Tania Rafaschieri, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Recenti Progressi in Medicina|January 29, 2021
[Efficacy of pralsetinib in a patient with advanced lung adenocarcinoma positive for RET rearrangement: the importance of Comprehensive Genomic Profiling.]Michele Montrone, Vito Longo, Annamaria Catino, et al.
Recenti Progressi in Medicina|November 2, 2012
[Bone health in the oncologic patient]Stella D'Oronzo, Antonella Tamma, Valeria Simone, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2020
Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinibMichele Montrone, Annamaria Catino, Vincenzo O Palmieri, et al.
Recenti Progressi in Medicina|February 24, 2021
[RET rearrangements in advanced lung cancer: a target to always look for.]Annamaria Catino, Pia Perrotti, Sandro Cassiano, et al.
Cancer Metastasis Reviews|December 21, 2013
Bone metastases in hepatocellular carcinoma: an emerging issueVito Longo, Oronzo Brunetti, Stella D'Oronzo, et al.
Clinical and Experimental Medicine|March 2, 2018
Mast cells and angiogenesis in pancreatic ductal adenocarcinomaVito Longo, Roberto Tamma, Oronzo Brunetti, et al.
Thoracic Cancer|November 5, 2022
Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decadeVito Longo, Pamela Pizzutilo, Annamaria Catino, et al.
Cancers|April 18, 2019
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic ReviewVito Longo, Oronzo Brunetti, Amalia Azzariti, et al.
Cancers|May 14, 2025
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-AnalysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Biomolecules|April 27, 2024
Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?Rossella Fasano, Simona Serratì, Tania Rafaschieri, et al.
Pageof 7